Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records

Marc Rosenman, Layla Baker, Yonghua Jing, Dinara Makenbaeva, Brian Meissner, Teresa A. Simon, Daniel Wiederkehr, Steve Deitelzweig

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: Automated electronic queries of structured data fields in electronic medical records (EMR) found no barriers to warfarin in 42 of patients with atrial fibrillation or atrial flutter (AF) with moderate or high risk of stroke and no warfarin. A thorough manual review of records (including text reports) from the same EMR may better identify physicians' reasons for not using warfarin. Methods: This was a cross-sectional, retrospective, manual EMR review. Patients identified in a previous automated EMR study with a CHADS2 (Chronic heart failure, Hypertension, Age >75 years, Diabetes mellitus, Stroke) score 2, no record of warfarin, no barrier to warfarin use, and (in the present study) confirmation of AF diagnosis were included in the manual EMR review. A structured chart abstraction form was used to extract data visible in the clinicians' EMR user interface. Reasons why warfarin had not been prescribed were reported using descriptive statistics. Results: Among 408 patients with 'no barriers' to warfarin in the automated EMR review, AF diagnosis was confirmed in 319 patients (mean age 74.8; 65 female). Forty-one percent (n=132) did not have chart records explaining why they were not on warfarin. Among the 59 (187) with a rationale against warfarin found in the records, the most common category (52) was indicative of the risk of bleeding, either risk of fall or history of recent bleeding. The second most common category (16) reflected that the patient was back in sinus rhythm. These findings are subject to inherent limitations of retrospective chart reviews. Conclusions: Many patients with AF and moderate-to-high risk of stroke are not treated with warfarin, and reasons for not using warfarin could not always be identified in patient records. Among patients with documented reasons, risk of bleeding (risk of fall or recent bleeding) was the most common category.

Original languageEnglish
Pages (from-to)1407-1414
Number of pages8
JournalCurrent Medical Research and Opinion
Volume28
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Electronic Health Records
Warfarin
Atrial Fibrillation
Stroke
Atrial Flutter
Hemorrhage
Diabetes Mellitus
Heart Failure
Hypertension
Physicians

Keywords

  • Anticoagulation
  • Atrial fibrillation
  • Stroke prevention
  • Warfarin

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records. / Rosenman, Marc; Baker, Layla; Jing, Yonghua; Makenbaeva, Dinara; Meissner, Brian; Simon, Teresa A.; Wiederkehr, Daniel; Deitelzweig, Steve.

In: Current Medical Research and Opinion, Vol. 28, No. 9, 09.2012, p. 1407-1414.

Research output: Contribution to journalArticle

Rosenman, Marc ; Baker, Layla ; Jing, Yonghua ; Makenbaeva, Dinara ; Meissner, Brian ; Simon, Teresa A. ; Wiederkehr, Daniel ; Deitelzweig, Steve. / Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records. In: Current Medical Research and Opinion. 2012 ; Vol. 28, No. 9. pp. 1407-1414.
@article{43ff3b24fad14993bf41f18f9fce6549,
title = "Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records",
abstract = "Objective: Automated electronic queries of structured data fields in electronic medical records (EMR) found no barriers to warfarin in 42 of patients with atrial fibrillation or atrial flutter (AF) with moderate or high risk of stroke and no warfarin. A thorough manual review of records (including text reports) from the same EMR may better identify physicians' reasons for not using warfarin. Methods: This was a cross-sectional, retrospective, manual EMR review. Patients identified in a previous automated EMR study with a CHADS2 (Chronic heart failure, Hypertension, Age >75 years, Diabetes mellitus, Stroke) score 2, no record of warfarin, no barrier to warfarin use, and (in the present study) confirmation of AF diagnosis were included in the manual EMR review. A structured chart abstraction form was used to extract data visible in the clinicians' EMR user interface. Reasons why warfarin had not been prescribed were reported using descriptive statistics. Results: Among 408 patients with 'no barriers' to warfarin in the automated EMR review, AF diagnosis was confirmed in 319 patients (mean age 74.8; 65 female). Forty-one percent (n=132) did not have chart records explaining why they were not on warfarin. Among the 59 (187) with a rationale against warfarin found in the records, the most common category (52) was indicative of the risk of bleeding, either risk of fall or history of recent bleeding. The second most common category (16) reflected that the patient was back in sinus rhythm. These findings are subject to inherent limitations of retrospective chart reviews. Conclusions: Many patients with AF and moderate-to-high risk of stroke are not treated with warfarin, and reasons for not using warfarin could not always be identified in patient records. Among patients with documented reasons, risk of bleeding (risk of fall or recent bleeding) was the most common category.",
keywords = "Anticoagulation, Atrial fibrillation, Stroke prevention, Warfarin",
author = "Marc Rosenman and Layla Baker and Yonghua Jing and Dinara Makenbaeva and Brian Meissner and Simon, {Teresa A.} and Daniel Wiederkehr and Steve Deitelzweig",
year = "2012",
month = "9",
doi = "10.1185/03007995.2012.708653",
language = "English",
volume = "28",
pages = "1407--1414",
journal = "Current Medical Research and Opinion",
issn = "0300-7995",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Why is warfarin underused for stroke prevention in atrial fibrillation? A detailed review of electronic medical records

AU - Rosenman, Marc

AU - Baker, Layla

AU - Jing, Yonghua

AU - Makenbaeva, Dinara

AU - Meissner, Brian

AU - Simon, Teresa A.

AU - Wiederkehr, Daniel

AU - Deitelzweig, Steve

PY - 2012/9

Y1 - 2012/9

N2 - Objective: Automated electronic queries of structured data fields in electronic medical records (EMR) found no barriers to warfarin in 42 of patients with atrial fibrillation or atrial flutter (AF) with moderate or high risk of stroke and no warfarin. A thorough manual review of records (including text reports) from the same EMR may better identify physicians' reasons for not using warfarin. Methods: This was a cross-sectional, retrospective, manual EMR review. Patients identified in a previous automated EMR study with a CHADS2 (Chronic heart failure, Hypertension, Age >75 years, Diabetes mellitus, Stroke) score 2, no record of warfarin, no barrier to warfarin use, and (in the present study) confirmation of AF diagnosis were included in the manual EMR review. A structured chart abstraction form was used to extract data visible in the clinicians' EMR user interface. Reasons why warfarin had not been prescribed were reported using descriptive statistics. Results: Among 408 patients with 'no barriers' to warfarin in the automated EMR review, AF diagnosis was confirmed in 319 patients (mean age 74.8; 65 female). Forty-one percent (n=132) did not have chart records explaining why they were not on warfarin. Among the 59 (187) with a rationale against warfarin found in the records, the most common category (52) was indicative of the risk of bleeding, either risk of fall or history of recent bleeding. The second most common category (16) reflected that the patient was back in sinus rhythm. These findings are subject to inherent limitations of retrospective chart reviews. Conclusions: Many patients with AF and moderate-to-high risk of stroke are not treated with warfarin, and reasons for not using warfarin could not always be identified in patient records. Among patients with documented reasons, risk of bleeding (risk of fall or recent bleeding) was the most common category.

AB - Objective: Automated electronic queries of structured data fields in electronic medical records (EMR) found no barriers to warfarin in 42 of patients with atrial fibrillation or atrial flutter (AF) with moderate or high risk of stroke and no warfarin. A thorough manual review of records (including text reports) from the same EMR may better identify physicians' reasons for not using warfarin. Methods: This was a cross-sectional, retrospective, manual EMR review. Patients identified in a previous automated EMR study with a CHADS2 (Chronic heart failure, Hypertension, Age >75 years, Diabetes mellitus, Stroke) score 2, no record of warfarin, no barrier to warfarin use, and (in the present study) confirmation of AF diagnosis were included in the manual EMR review. A structured chart abstraction form was used to extract data visible in the clinicians' EMR user interface. Reasons why warfarin had not been prescribed were reported using descriptive statistics. Results: Among 408 patients with 'no barriers' to warfarin in the automated EMR review, AF diagnosis was confirmed in 319 patients (mean age 74.8; 65 female). Forty-one percent (n=132) did not have chart records explaining why they were not on warfarin. Among the 59 (187) with a rationale against warfarin found in the records, the most common category (52) was indicative of the risk of bleeding, either risk of fall or history of recent bleeding. The second most common category (16) reflected that the patient was back in sinus rhythm. These findings are subject to inherent limitations of retrospective chart reviews. Conclusions: Many patients with AF and moderate-to-high risk of stroke are not treated with warfarin, and reasons for not using warfarin could not always be identified in patient records. Among patients with documented reasons, risk of bleeding (risk of fall or recent bleeding) was the most common category.

KW - Anticoagulation

KW - Atrial fibrillation

KW - Stroke prevention

KW - Warfarin

UR - http://www.scopus.com/inward/record.url?scp=84866714172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866714172&partnerID=8YFLogxK

U2 - 10.1185/03007995.2012.708653

DO - 10.1185/03007995.2012.708653

M3 - Article

VL - 28

SP - 1407

EP - 1414

JO - Current Medical Research and Opinion

JF - Current Medical Research and Opinion

SN - 0300-7995

IS - 9

ER -